Location History:
- Boston, MA (US) (2002)
- Zurich, CH (2005)
Company Filing History:
Years Active: 2002-2005
Title: Michael Hengartner: Innovator in Cell Death Protection
Introduction
Michael Hengartner is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of genetics, particularly in understanding the mechanisms of programmed cell death. His work has implications for various medical and environmental applications.
Latest Patents
Hengartner holds 2 patents related to the identification and characterization of genes that protect cells from programmed cell death. His latest patents focus on a gene known as ced-9, which has been identified, sequenced, and characterized. This gene plays a crucial role in protecting cells from apoptosis by antagonizing the activities of cell death genes. The research highlights the potential for developing methods and agents that can either increase or decrease cell death, which could be beneficial for diagnosing and treating diseases, as well as addressing environmental concerns.
Career Highlights
Throughout his career, Hengartner has worked at prestigious institutions such as the Massachusetts Institute of Technology and ETH Zurich. His research has garnered attention for its innovative approach to understanding cellular processes and their implications for health and disease.
Collaborations
Hengartner has collaborated with notable scientists, including H Robert Horvitz and Markus Kunzler. These partnerships have contributed to the advancement of knowledge in the field of genetics and cell biology.
Conclusion
Michael Hengartner's work in identifying cell death-protective genes has opened new avenues for research and potential therapeutic applications. His contributions continue to influence the scientific community and pave the way for future innovations in genetics.